Zobrazeno 1 - 10
of 126
pro vyhledávání: '"JP Eder"'
Publikováno v:
Blood. 76(11)
To investigate the potential role of recombinant human erythropoietin (rhEpo) in patients receiving intensive cytotoxic therapy, we measured the endogenous levels of Epo in 31 patients undergoing bone marrow transplantation (BMT). Seventeen patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c9caec488b15b904f87862c2176aa78
https://pubmed.ncbi.nlm.nih.gov/2257306
https://pubmed.ncbi.nlm.nih.gov/2257306
Autor:
Blanter J; Icahn School of Medicine at Mount Sinai, New York, NY., Van Hyfte G; Icahn School of Medicine at Mount Sinai, New York, NY., Ahmad M; Yale University School of Medicine, New Haven, CT., Xu S; Johns Hopkins School of Medicine, Baltimore, MD., Hapanowicz O; Icahn School of Medicine at Mount Sinai, New York, NY., Fazilov G; Icahn School of Medicine at Mount Sinai, New York, NY., Lu A; Icahn School of Medicine at Mount Sinai, New York, NY., Lucas N; Icahn School of Medicine at Mount Sinai, New York, NY., Wu K; Icahn School of Medicine at Mount Sinai, New York, NY., Shelton G; Icahn School of Medicine at Mount Sinai, New York, NY., DeMerchant M; Yale Cancer Center, New Haven, CT., Lachowicz M; Yale Cancer Center, New Haven, CT.; Arvinas, Inc., Kier M; Icahn School of Medicine at Mount Sinai, New York, NY., Werner M; Zucker School of Medicine at Hofstra/Northwell Health, New Hyde Park, NY., Eder JP; Yale Cancer Center, New Haven, CT.; Parthenon Therapeutics., Galsky MD; Icahn School of Medicine at Mount Sinai, New York, NY., Marron TU; Icahn School of Medicine at Mount Sinai, New York, NY., Smith CB; Icahn School of Medicine at Mount Sinai, New York, NY., LoRusso PM; Yale Cancer Center, New Haven, CT., Hofstatter E; Yale Cancer Center, New Haven, CT.; GlaxoSmithKline, Inc., Doroshow DB; Icahn School of Medicine at Mount Sinai, New York, NY.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2024 Dec 11, pp. OP2400293. Date of Electronic Publication: 2024 Dec 11.
Autor:
Segal NH; Memorial Sloan Kettering Cancer Center, New York, NY, United States; Weill Cornell Medical College, New York, NY, USA. segaln@mskcc.org., Melero I; Clínica Universidad de Navarra and CIMA University of Navarra, Navarra, Spain.; CIBERONC, Instituto de Salud Carlso III, Madrid, Spain., Moreno V; Hospital Fundación Jiménez Díaz, Madrid, Spain., Steeghs N; Netherlands Cancer Institute, Amsterdam, Netherlands., Marabelle A; Gustave Roussy, Université Paris-Saclay, Villejuif, France., Rohrberg K; Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Rodriguez-Ruiz ME; Clínica Universidad de Navarra and CIMA University of Navarra, Navarra, Spain., Eder JP; Yale University Cancer Center, New Haven, CT, USA., Eng C; Vanderbilt Ingram Cancer Center, Nashville, TN, USA., Manji GA; Columbia University, New York, NY, USA., Waterkamp D; Genentech, Inc., South San Francisco, CA, USA., Leutgeb B; F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Bouseida S; F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Flinn N; F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Das Thakur M; Genentech, Inc., South San Francisco, CA, USA., Elze MC; F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Koeppen H; Genentech, Inc., South San Francisco, CA, USA., Jamois C; F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Martin-Facklam M; F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Lieu CH; University of Colorado, Aurora, Denver, CO, USA., Calvo E; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain., Paz-Ares L; University Hospital 12 de Octubre, Madrid, Spain., Tabernero J; Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), Barcelona, Spain., Argilés G; Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), Barcelona, Spain.; Departament de Cirurgia, Universitat Autònoma de Barcelona, Barcelona, Spain.
Publikováno v:
Nature communications [Nat Commun] 2024 May 15; Vol. 15 (1), pp. 4091. Date of Electronic Publication: 2024 May 15.
Autor:
Hu Y; Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT., Narayan A; Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT., Xu Y; Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT., Wolfe J; Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT., Vu D; Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT., Trinh T; Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT., Kantak C; Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT., Ivy SP; National Cancer Institute, National Institutes of Health, Bethesda, MD., Eder JP; Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT.; Parthenon Therapeutics, Cambridge, MA., Deng Y; Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT., LoRusso P; Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT., Kim JW; Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT., Patel AA; Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2024 Feb; Vol. 8, pp. e2300289.
Autor:
Doroshow DB; Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY, USA., Wei W; Yale School of Public Health, New Haven, CT, USA., Mehrotra M; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Sia D; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Eder JP; Yale School of Medicine, New Haven, CT, USA.; Yale Cancer Center, New Haven, CT, USA., Bindra R; Yale Cancer Center, New Haven, CT, USA., Houldsworth J; Icahn School of Medicine at Mount Sinai, New York, NY, USA., LoRusso P; Yale School of Medicine, New Haven, CT, USA.; Yale Cancer Center, New Haven, CT, USA., Walther Z; Yale School of Medicine, New Haven, CT, USA.; Yale Cancer Center, New Haven, CT, USA.
Publikováno v:
Cancer investigation [Cancer Invest] 2023 Sep; Vol. 41 (7), pp. 646-655. Date of Electronic Publication: 2023 Aug 17.
Autor:
Cecchini M; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut., Walther Z; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut., Wei W; Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut., Hafez N; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut., Pilat MJ; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Boerner SA; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut., Durecki DE; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut., Eder JP; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut., Schalper KA; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut., Chen AP; Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., LoRusso P; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2023 Jun 26; Vol. 3 (6), pp. 1113-1117. Date of Electronic Publication: 2023 Jun 26 (Print Publication: 2023).
Autor:
Clifton GT; Parthenon Therapeutics, Boston, Massachusetts, USA Travis@parthenontx.com., Rothenberg M; Consultant, Parthenon Therapeutics, Boston, Massachusetts, USA., Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, IRCCS Fondazione 'G. Pascale', Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, Italy., Begley G; Parthenon Therapeutics, Boston, Massachusetts, USA., Cecchini M; Department of Internal Medicine, Division of Medical Oncology, Yale School of Medicine, New Haven, Connecticut, USA., Eder JP; Parthenon Therapeutics, Boston, Massachusetts, USA., Ghiringhelli F; Department of Medical Oncology, Georges François Leclerc Cancer Center-UNICANCER, Dijon, France., Italiano A; Early Phase Trial Unit, Institut Bergonié, Bordeaux 33000, France., Kochetkova M; Centre for Cancer Biology, University of South Australia, Adelaide, South Australia, Australia., Li R; Department of Biochemistry and Molecular Medicine, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA., Mechta-Grigoriou F; Stress and Cancer Laboratory, Institut Curie, INSERM, Paris, France., Pai SI; Department of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Provenzano P; Department of Biomedical Engineering, University of Minnesota System, Minneapolis, Minnesota, USA., Puré E; Department of Biomedical Sciences, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pennsylvania, USA., Ribas A; Division of Hematology and Oncology, UCLA David Geffen School of Medicine, Los Angeles, California, USA., Schalper KA; Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA., Fridman WH; Department of Immunology, Inflammation and Cancer, Centre de Recherche des Cordeliers, Paris, France.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Jun; Vol. 11 (6).
Autor:
Jimenez-Sainz J; Department of Therapeutic Radiology, Yale University, New Haven, United States., Mathew J; Department of Therapeutic Radiology, Yale University, New Haven, United States., Moore G; Department of Therapeutic Radiology, Yale University, New Haven, United States., Lahiri S; Department of Therapeutic Radiology, Yale University, New Haven, United States., Garbarino J; Department of Therapeutic Radiology, Yale University, New Haven, United States., Eder JP; Department of Medical Oncology, Yale University School of Medicine, Yale Cancer Center, New Haven, United States., Rothenberg E; Department of Biochemistry and Molecular Pharmacology, New York University, New York, United States., Jensen RB; Department of Therapeutic Radiology, Yale University, New Haven, United States.
Publikováno v:
ELife [Elife] 2022 Sep 13; Vol. 11. Date of Electronic Publication: 2022 Sep 13.
Autor:
Atrafi F, Boix O, Subbiah V, Diamond JR, Chawla SP, Tolcher AW, LoRusso PM, Eder JP, Gutierrez M, Sankhala K, Rajagopalan P, Genvresse I, Langer S, Mathijssen RHJ, Verweij J, Bruns I, Lolkema MP
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Jul 01; Vol. 28 (13), pp. 2969.
Autor:
Eder JP; Joseph Paul Eder, MD, Early Drug Development Program, Oncology Firm Chief for Practice & Education, Yale Cancer Center, New Haven, CT.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2022 Jun; Vol. 6, pp. e2200136.